Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Can Split Renal Volume Assessment by Computed Tomography Replace Nuclear Split Renal Function in Living Kidney Donor Evaluations? A Systematic Review and Meta-Analysis.

Habbous S, Garcia-Ochoa C, Brahm G, Nguan C, Garg AX.

Can J Kidney Health Dis. 2019 Sep 19;6:2054358119875459. doi: 10.1177/2054358119875459. eCollection 2019.

2.

HPV Status Improves Classification of Head and Neck Gray Zone Cancers.

Ren J, Xu W, Su J, Ren X, Bender N, Habbous S, de Almeida JR, Goldstein DP, Cheng D, Chen Z, Mirshams M, Rahini M, Huang SH, Spreafico A, Hansen A, Kim J, Waldron J, Perez-Ordonez B, Zhao Y, Hung R, Waterboer T, Liu G.

J Dent Res. 2019 Jul;98(8):879-887. doi: 10.1177/0022034519853771.

PMID:
31282843
3.

Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.

Ren J, Xu W, Su J, Ren X, Cheng D, Chen Z, Bender N, Mirshams M, Habbous S, de Almeida JR, Perez-Ordonez B, Goldstein DP, Wang JR, Bratman SV, Huang SH, Jang R, Zhao Y, Waterboer T, Hung RJ, Liu G.

Int J Cancer. 2020 Apr 15;146(8):2166-2174. doi: 10.1002/ijc.32548. Epub 2019 Jul 23.

PMID:
31269236
4.

Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region.

Ren J, Yang W, Su J, Ren X, Fazelzad R, Albert T, Habbous S, Goldstein DP, de Almeida JR, Hansen A, Jang R, Bratman SV, Hope A, Chen R, Wang J, Xu Y, Cheng D, Zhao Y, Xu W, Liu G.

Int J Cancer. 2019 Sep 15;145(6):1465-1474. doi: 10.1002/ijc.32164. Epub 2019 Feb 19.

PMID:
30698281
5.

The Efficiency of Evaluating Candidates for Living Kidney Donation: A Scoping Review.

Habbous S, Woo J, Lam NN, Lentine KL, Cooper M, Reich M, Garg AX.

Transplant Direct. 2018 Sep 20;4(10):e394. doi: 10.1097/TXD.0000000000000833. eCollection 2018 Oct.

6.

Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.

Habbous S, Sarma S, Barnieh LJ, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.

PMID:
30044364
7.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
8.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Go┼║dzik D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

9.

Potential implications of a more timely living kidney donor evaluation.

Habbous S, McArthur E, Sarma S, Begen MA, Lam NN, Manns B, Lentine KL, Dipchand C, Litchfield K, McKenzie S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2018 Nov;18(11):2719-2729. doi: 10.1111/ajt.14732. Epub 2018 Apr 17.

10.

Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.

Habbous S, Przech S, Martin J, Garg AX, Sarma S.

Value Health. 2018 Mar;21(3):318-325. doi: 10.1016/j.jval.2017.08.3020. Epub 2017 Oct 18.

11.

Initiating Maintenance Dialysis Before Living Kidney Donor Transplantation When a Donor Candidate Evaluation Is Well Underway.

Habbous S, McArthur E, Dixon SN, McKenzie S, Garcia-Ochoa C, Lam NN, Lentine KL, Dipchand C, Litchfield K, Begen MA, Sarma S, Garg AX.

Transplantation. 2018 Jul;102(7):e345-e353. doi: 10.1097/TP.0000000000002159.

PMID:
29538259
12.

Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation.

Habbous S, Chu KP, Lau H, Schorr M, Belayneh M, Ha MN, Murray S, O'Sullivan B, Huang SH, Snow S, Parliament M, Hao D, Cheung WY, Xu W, Liu G.

CMAJ. 2017 Aug 14;189(32):E1030-E1040. doi: 10.1503/cmaj.161379.

13.

Body mass index and prognosis in patients with head and neck cancer.

Gama RR, Song Y, Zhang Q, Brown MC, Wang J, Habbous S, Tong L, Huang SH, O'Sullivan B, Waldron J, Xu W, Goldstein D, Liu G.

Head Neck. 2017 Jun;39(6):1226-1233. doi: 10.1002/hed.24760. Epub 2017 Mar 21.

PMID:
28323362
14.

The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis.

Habbous S, Przech S, Acedillo R, Sarma S, Garg AX, Martin J.

Nephrol Dial Transplant. 2017 Jan 1;32(1):111-125. doi: 10.1093/ndt/gfw312. Review.

PMID:
27651467
15.

Socioeconomic status, human papillomavirus, and overall survival in head and neck squamous cell carcinomas in Toronto, Canada.

Chu KP, Habbous S, Kuang Q, Boyd K, Mirshams M, Liu FF, Espin-Garcia O, Xu W, Goldstein D, Waldron J, O'Sullivan B, Huang SH, Liu G.

Cancer Epidemiol. 2016 Feb;40:102-12. doi: 10.1016/j.canep.2015.11.010. Epub 2015 Dec 17.

PMID:
26706365
16.

Appraisal of a redundant report on lanthanum carbonate.

Habbous S, Garg AX, Martin J.

Int Urol Nephrol. 2016 Jan;48(1):149-50. doi: 10.1007/s11255-015-1159-x. Epub 2015 Nov 17. No abstract available.

PMID:
26578000
17.

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.

Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS.

Cancer. 2015 Jun 1;121(11):1785-92. doi: 10.1002/cncr.29111. Epub 2015 Apr 13.

18.

Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.

Wang JR, Habbous S, Espin-Garcia O, Chen D, Huang SH, Simpson C, Xu W, Liu FF, Brown DH, Gilbert RW, Gullane PJ, Irish JC, Goldstein DP, Liu G.

Head Neck. 2016 May;38(5):736-42. doi: 10.1002/hed.23947. Epub 2015 Jun 25.

PMID:
25521753
19.

Gestational hypertension and preeclampsia in living kidney donors.

Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL; DONOR Network.

N Engl J Med. 2015 Jan 8;372(2):124-33. doi: 10.1056/NEJMoa1408932. Epub 2014 Nov 14.

20.

Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis.

Habbous S, Pang V, Xu W, Amir E, Liu G.

J Clin Virol. 2014 Oct;61(2):220-9. doi: 10.1016/j.jcv.2014.07.019. Epub 2014 Aug 7. Review.

PMID:
25174543
21.

Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.

Wong KM, Qiu X, Cheng D, Azad AK, Habbous S, Palepu P, Mirshams M, Patel D, Chen Z, Roberts H, Knox J, Marquez S, Wong R, Darling G, Waldron J, Goldstein D, Leighl N, Shepherd FA, Tsao M, Der S, Reisman D, Liu G.

Cancer Med. 2014 Apr;3(2):426-33. doi: 10.1002/cam4.201. Epub 2014 Feb 12.

22.

Second-hand smoke as a predictor of smoking cessation among lung cancer survivors.

Eng L, Su J, Qiu X, Palepu PR, Hon H, Fadhel E, Harland L, La Delfa A, Habbous S, Kashigar A, Cuffe S, Shepherd FA, Leighl NB, Pierre AF, Selby P, Goldstein DP, Xu W, Liu G.

J Clin Oncol. 2014 Feb 20;32(6):564-70. doi: 10.1200/JCO.2013.50.9695. Epub 2014 Jan 13.

PMID:
24419133
23.

The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.

Habbous S, Chu KP, Qiu X, La Delfa A, Harland LT, Fadhel E, Hui A, Perez-Ordonez B, Weinreb I, Liu FF, Waldron J, O'Sullivan B, Goldstein D, Xu W, Huang SH, Liu G.

Cancer Epidemiol. 2013 Dec;37(6):820-9. doi: 10.1016/j.canep.2013.09.011. Epub 2013 Nov 1.

PMID:
24184275
24.

Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients.

Kashigar A, Habbous S, Eng L, Irish B, Bissada E, Irish J, Brown D, Gilbert R, Gullane P, Xu W, Huang SH, Witterick I, Freeman J, O'Sullivan B, Waldron J, Liu G, Goldstein D.

Cancer. 2013 Aug 1;119(15):2701-9. doi: 10.1002/cncr.28088. Epub 2013 Jun 13. Erratum in: Cancer. 2013 Nov 1;119(21):3895-6.

25.

Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.

Habbous S, Harland LT, La Delfa A, Fadhel E, Xu W, Liu FF, Goldstein D, Waldron J, Huang SH, O'Sullivan B, Liu G.

Head Neck. 2014 Jun;36(6):802-10. doi: 10.1002/hed.23360. Epub 2013 Jul 30.

PMID:
23616414
26.

Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.

Habbous S, Chu KP, Harland LT, La Delfa A, Fadhel E, Sun B, Xu W, Wong A, Howell D, Ringash J, Waldron J, O'Sullivan B, Goldstein D, Huang SH, Liu G.

Oral Oncol. 2013 May;49(5):407-12. doi: 10.1016/j.oraloncology.2012.11.010. Epub 2013 Jan 4.

PMID:
23291295
27.

p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.

Habbous S, Pang V, Eng L, Xu W, Kurtz G, Liu FF, Mackay H, Amir E, Liu G.

Clin Cancer Res. 2012 Dec 1;18(23):6407-15. doi: 10.1158/1078-0432.CCR-12-1983. Epub 2012 Oct 12. Review.

28.

Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis.

Eng L, Azad AK, Habbous S, Pang V, Xu W, Maitland-van der Zee AH, Savas S, Mackay HJ, Amir E, Liu G.

Clin Cancer Res. 2012 Sep 1;18(17):4526-37. Epub 2012 Jun 25.

Supplemental Content

Loading ...
Support Center